2nd Quarter - Amendment — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2014)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

Support for United nations Disability Rights Treaty CRPD

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; Natl Institutes of Health (NIH); SENATE

Budget/Appropriations BUD

Labor, HHS, Education and Related Agencies appropriations for NIH,CDC, and FDA Funding for Lifespan Respite Care Act Funding for epilepsy research and programs Prescription drug access issue appropriations

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office

Health Issues HCR

Health care reform implementation Medicare and Medicaid coverage issues Medicare policy reform Support for epilepsy awareness programs

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.